Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells

Apoptosis

Volumn 2, Issue 1, 1997, Pages 101-105

  Yuan, C C ^a,b   Huang, H C ^c   Tsai, L C ^d   Ng, H T ^a,b   Huang, T S ^a,e  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d VGH TAIPEI   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Apoptosis; Cytokeratin; Drug resistance

Indexed keywords

EID: 1842366439     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026448027870     Document Type: Article

References (21)

1. Rutanen EM, Lindgren J, Sipponen P, Stenman UH, Saksela E, Seppala M. Carcinoembryonic antigen in malignant and non-malignant gynecologic tumors. Cancer 1978; 42: 581-590.
2. Kato H, Myauchi F, Morioka H, Fujino T, Torigoe T. Tumor antigen of human cervical squamous cell carcinoma. Correlation of circulating levels with disease progress. Cancer 1979; 43: 585-590.
3. Bamford PN, Ormerod MG, Sloane JP, Warburton MJ. An immunohistochemical study of the distribution of epithelial antigens in the uterine cervix. Obstet Gynecol 1983;61:603-608.
4. Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH, Ng HT. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers. Chin Med J (Taipei) 1992; 50: 7-13.
5. Yuan CC, Tsai LC, Hsu SC, et al. Production and characterization of a monoclonal antibody (Cx-99) against cervical carcinoma. Br J Cancer 1992; 65: 201-207.
6. Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA 1994; 91: 5311-5314.
7. Anderson JM, Heindl LH, Bauman PA, Ludi CW, Dalton WS, Cress AE. Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents. Clin Cancer Res 1996; 2: 97-105.
8. Ferdeghini M, Gadducci A, Annicchiarico C, et al. Serum CY-FRA 21-1 assay in squamous cell carcinoma of the cervix. Anticancer Res 1993; 13: 1841-1844.
9. Huang T-S, Yang WK, Whang-Peng J. GL331-induced disruption of cyclin B1/CDC2 complex and inhibition of CDC 2 kinase activity. Apoptosis 1996; 1: 213-217.
10. Huang T-S, Shu C-H, Shih Y-L, et al. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 1996; 110: 77-85.
11. Shu C-H, Yang WK, Huang T-S. Increased cyclin B1/CDC2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 1996; 1: 141-146.
12. Traub P. Intermediate Filaments: A Review. Berlin, Germany: Springer, 1985.
13. Roberts RA, Cress AE, Dalton WS. Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. Biochem Pharmacol 1989; 38: 4283-4290.
14. Martin SJ, Green DR, Cotter TG. Dicing with death dissecting the components of the apoptosis machinery. Trends Biochem Sci 1994; 19: 26-30.
15. Miyashita T, Reed JC. bcl-2 gene transfer increase relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic agents. Cancer Res 1992; 52: 5407-5411.
16. Ling YH, Priebe W, Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 1993; 53: 1845-1852.
17. Kuo M-L, Huang T-S, Lin J-K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1996; 1317: 95-100.
18. Knapp LW, O'Guin WM, Sawyer RH. Drug-induced alterations of cytokeratin organization in cultured epithelial cells. Science 1983; 219: 501-503.
19. Nagle RB. Biochemical and Molecular Aspects of Selected Cancers. Pretlow TG, Pretlow TP, eds. Orlando, FL (USA): Academic, 1993.
20. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
21. Stieber P, Bodenmuller H, Banauch D, et al. Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer. Clin Biochem 1993; 26: 301-304.